SEC Form 4 · accession 0001562180-17-003163
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John H Weiland
Director
Period of report
Sep 29, 2017
Accepted (ET)
Oct 3, 2017 · 3:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 43,535 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Phantom Stock UnitF1,F2 | — | Sep 29, 2017 | A | 234 | A | — | — | Common Stock | 234 | 24,367 | D |
Explanation of responses
- F1Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.
- F2Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.